Brief: Chemometec Says In 2022/23 FY, Revenue Grew By 4% To Dkk 442.3 Million
Sept 13 (Reuters) - Chemometec A/S CHEMM.CO :
* IN 2022/23 FINANCIAL YEAR, REVENUE GREW BY 4% TO DKK 442.3
MILLION
* OPERATING PROFIT (EBITDA) AMOUNTED TO DKK 251.0 MILLION IN
2022/23, A 13% INCREASE ON 2021/22
* BOARD OF DIRECTORS PROPOSES TO GENERAL MEETING THAT A
DIVIDEND
OF DKK 6.0 PER SHARE BE DISTRIBUTED FOR 2022/23 FINANCIAL YEAR
Source text for Eikon: ID:nGNE7lzlFK
Further company coverage: CHEMM.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation